Analyzing Bonk (BNKK) & Its Peers

Bonk (NASDAQ:BNKK) is one of 345 public companies in the “Financial Services” industry, but how does it contrast to its competitors? We will compare Bonk to similar companies based on the strength of its profitability, risk, earnings, dividends, analyst recommendations, valuation and institutional ownership.

Institutional and Insider Ownership

12.6% of Bonk shares are owned by institutional investors. Comparatively, 43.0% of shares of all “Financial Services” companies are owned by institutional investors. 51.6% of Bonk shares are owned by insiders. Comparatively, 21.8% of shares of all “Financial Services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Bonk and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bonk	1	0	0	0	1.00
Bonk Competitors	1891	6807	11500	414	2.51

As a group, “Financial Services” companies have a potential upside of 4.09%. Given Bonk’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Bonk has less favorable growth aspects than its competitors.

Profitability

This table compares Bonk and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bonk	-952.21%	-137.47%	-122.67%
Bonk Competitors	-405.59%	-21.92%	-5.67%

Risk and Volatility

Bonk has a beta of 2.04, indicating that its stock price is 104% more volatile than the S&P 500. Comparatively, Bonk’s competitors have a beta of 2.26, indicating that their average stock price is 126% more volatile than the S&P 500.

Earnings & Valuation

This table compares Bonk and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Bonk	$2.12 million	-$68.19 million	-0.32
Bonk Competitors	$24.20 billion	$1.07 billion	10.49

Bonk’s competitors have higher revenue and earnings than Bonk. Bonk is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Bonk competitors beat Bonk on 12 of the 13 factors compared.

Bonk Company Profile

Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. The company was incorporated in 2018 and is headquartered in Jupiter, Florida.